Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. CVS Health Corporation
  6. News
  7. Summary
    CVS   US1266501006

CVS HEALTH CORPORATION

(CVS)
  Report
Delayed Nyse  -  05/27 04:00:02 pm EDT
98.05 USD   +0.26%
05/27WALL STREET STOCK EXCHANGE : Wall Street on track to end the week in the green
05/27ANALYST RECOMMENDATIONS : Boston Scientific, Dollar General, Dollar Tree, Macy's, VMWare...
05/27Bernstein Downgrades CVS Health to Market Perform From Outperform; Price Target is $112
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

CVS Health, Uber to Provide Free Transportation Under New Health Zones Initiative

01/19/2022 | 09:18am EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
CVS HEALTH CORPORATION 0.26% 98.05 Delayed Quote.-4.95%
UBER TECHNOLOGIES, INC. 2.47% 23.67 Delayed Quote.-43.55%
All news about CVS HEALTH CORPORATION
05/27WALL STREET STOCK EXCHANGE : Wall Street on track to end the week in the green
05/27ANALYST RECOMMENDATIONS : Boston Scientific, Dollar General, Dollar Tree, Macy's, VMWare....
05/27Bernstein Downgrades CVS Health to Market Perform From Outperform; Price Target is $112
MT
05/25REPORT : CVS ends filling prescriptions connected with Cerebral, Done Health
AQ
05/25TIMELINE : Baby formula crunch in U.S. forces scramble to boost supplies
RE
05/20GLOBAL ACCESSIBILITY AWARENESS DAY : What accessibility means to CVS Health
PU
05/20OmniLife Named Winner of the 2022 Lyfebulb-CVS Kidney Care® Innovation Challenge
PR
05/20Baby formula crunch in U.S. forces scramble to boost supplies
RE
05/19Aetna Donates $225,000 to Iowa Community Health Partners
PR
05/16CVS HEALTH CORP : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
More news
Analyst Recommendations on CVS HEALTH CORPORATION
More recommendations
Financials (USD)
Sales 2022 309 B - -
Net income 2022 9 359 M - -
Net Debt 2022 38 781 M - -
P/E ratio 2022 14,0x
Yield 2022 2,18%
Capitalization 129 B 129 B -
EV / Sales 2022 0,54x
EV / Sales 2023 0,51x
Nbr of Employees 258 000
Free-Float 74,5%
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 98,05 $
Average target price 117,77 $
Spread / Average Target 20,1%
EPS Revisions
Managers and Directors
Karen S. Lynch President, Chief Executive Officer & Director
Shawn M. Guertin Chief Financial Officer & Executive Vice President
Roger N. Farah Chairman
Sreekanth Chaguturu Chief Medical Officer & Executive Vice President
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
Sector and Competitors
1st jan.Capi. (M$)
CVS HEALTH CORPORATION-4.95%128 574
HCA HEALTHCARE, INC.-16.10%63 692
LABORATORY CORPORATION OF AMERICA HOLDINGS-17.93%23 905
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY37.79%20 751
FRESENIUS MEDICAL CARE AG & CO. KGAA-0.98%17 762
QUEST DIAGNOSTICS-15.96%17 064